EUCTR2005-002647-35-IT进行中（未招募）不适用
epafenac 0.1 Eye Drops, Suspension compared to Ketorolac Trometamol 0.5 Eye Drops, Solution and Placebo Nepafenac Vehicle for the Prevention and Treatment of Ocular Inflammation and Ocular pain associated with Cataract Surgery European Study.
ALCON ITALIA0 个研究点开始时间: 2006年2月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
epafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated with Cataract Surgery. European Study.ocular pain and inflammation associated with cataract extraction and intraocular lens implantationEUCTR2005-002647-35-GBAlcon Research, Ltd
进行中（未招募）
1 期
epafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution & Placebo (Nepafenac Vehicle) for the Prevention & Treatment of Ocular Inflammation & Ocular Pain Associated with Cataract Surgery. European Study.Nepafenaco 0,1% colirio suspensión comparado con Ketorolaco trometamol 0,5% colirio solución y placebo (vehículo de Nepafenaco) en prevención y tratamiento de la inflamación ocular y del dolor ocular asociados a la cirugía de catarata: Estudio Europeo. - nepafenac ophthalmic Eocular pain and inflammation associated with cataract extraction and intraocular lens implantationEUCTR2005-002647-35-ESAlcon Research, Ltd225
进行中（未招募）
1 期
epafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated with Cataract Surgery. European Study.ocular pain and inflammation associated with cataract extraction and intraocular lens implantationEUCTR2005-002647-35-HUAlcon Research, Ltd
进行中（未招募）
不适用
epafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Ocular Pain Associated with Cataract Surgery. European Study. - Nepafenac Ophthalmic Eocular pain and inflammation associated with cataract extraction and intraocular lens implantationEUCTR2005-002647-35-PTAlcon Research, Ltd225
已完成
3 期
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and PlaceboCataractsNCT00405730Alcon Research227